View Older Stories View More Recent Stories
-
Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets
-
Instant View: Sanae Takaichi becomes Japan's first female prime minister
-
Citizens Downgrades Planet Labs (PL) to Market Perform
-
OSB GROUP PLC - Transaction in Own Shares
-
Auna launches tender offer for $373 million in notes due 2029
-
Auna S.A. Announces Commencement of Cash Tender Offer and Consent Solicitation of Any and All of Its Outstanding 10.000% Senior Secured Notes Due 2029
-
US banks hunting for collateral to back $20 billion Argentina bailout, WSJ reports
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Synovus Financial (SNV) PT Lowered to $62 at Citi
-
Investors see IMF support as crucial for Bolivia's new president
-
Mineros Announces Investor Meetings for Senior Notes
-
Chief Appoints Roshanie Ross as Chief Experience Officer, a Customer-Obsessed Leader Driving Innovation Across the Member Journey
-
Shopify (SHOP): Citizens Sees Agentic Commerce Growth Driver, Reiterates at Market Outperform
-
U.S. Physical Therapy (USPH): Citizens Sees Strong Growth Outlook, Reiterates at Outperform
-
Citizens Highlights Summit’s (SMMT) Ivonescimab Superiority, Reiterates at Outperform
-
Citizens Highlights Kura Oncology’s (KURA) KO-2806 Potential, Reiterates at Outperform
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC


